A detailed history of Royal Bank Of Canada transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 9,416 shares of PAHC stock, worth $203,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,416
Previous 9,232 1.99%
Holding current value
$203,762
Previous $154,000 37.01%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.39 - $22.5 $3,015 - $4,140
184 Added 1.99%
9,416 $211,000
Q2 2024

Aug 14, 2024

BUY
$12.44 - $18.55 $19,580 - $29,197
1,574 Added 20.55%
9,232 $154,000
Q1 2024

Nov 05, 2024

SELL
$10.63 - $13.68 $16,731 - $21,532
-1,574 Reduced 17.05%
7,658 $99,000
Q1 2024

May 15, 2024

SELL
$10.63 - $13.68 $65,172 - $83,872
-6,131 Reduced 44.46%
7,658 $99,000
Q4 2023

Feb 14, 2024

BUY
$9.59 - $12.91 $31,685 - $42,654
3,304 Added 31.51%
13,789 $159,000
Q3 2023

Nov 14, 2023

BUY
$12.43 - $15.29 $16,121 - $19,831
1,297 Added 14.12%
10,485 $133,000
Q2 2023

Aug 14, 2023

BUY
$12.92 - $15.89 $9,625 - $11,838
745 Added 8.82%
9,188 $125,000
Q1 2023

May 15, 2023

SELL
$13.67 - $16.37 $26,519 - $31,757
-1,940 Reduced 18.68%
8,443 $129,000
Q4 2022

Feb 14, 2023

BUY
$12.05 - $15.14 $120,584 - $151,505
10,007 Added 2661.44%
10,383 $139,000
Q3 2022

Nov 14, 2022

SELL
$12.82 - $20.22 $25,524 - $40,258
-1,991 Reduced 84.11%
376 $5,000
Q2 2022

Aug 15, 2022

SELL
$17.89 - $20.47 $21,611 - $24,727
-1,208 Reduced 33.79%
2,367 $45,000
Q1 2022

May 16, 2022

SELL
$18.39 - $21.85 $40,145 - $47,698
-2,183 Reduced 37.91%
3,575 $71,000
Q4 2021

Feb 14, 2022

SELL
$18.96 - $22.76 $378,612 - $454,494
-19,969 Reduced 77.62%
5,758 $117,000
Q3 2021

Nov 15, 2021

BUY
$20.59 - $30.01 $10,892 - $15,875
529 Added 2.1%
25,727 $554,000
Q2 2021

Aug 16, 2021

BUY
$24.15 - $30.08 $608,531 - $757,955
25,198 New
25,198 $727,000

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $440M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.